Talcum Powder Litigation Report
Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
SEARCH THE ARCHIVES
Ky. Plaintiffs Ask Talcum Powder MDL Court to Remand Claims, Say Local Radiology Department is Proper Defendant
Kentucky residents with talcum powder claims pending in the national multidistrict litigation docket in New Jersey have asked the MDL Court to remand their lawsuit, challenging Johnson & Johnson’s position that an in-state defendant was fraudulently joined.
Defendants Point to Full Study Questioning Link Between Talc and Ovarian Cancer; Plaintiffs Say Defense Letter Lacks ‘Context’
Parties involved in the national multidistrict litigation docket for talcum powder personal injury claims have exchanged correspondence on the full release of a study examining a potential link between talcum powder usage and ovarian cancer, with the plaintiffs maintaining that the full study supports the opinions expressed by plaintiffs’ experts.
Defendants are urging the judge overseeing the federal talcum powder MDL docket to disregard four peer-reviewed publications published since the court oversaw a Daubert hearing in July, arguing that they do not bolster the reliability of plaintiffs’ experts’ opinions.
Issue #37, December 2019
A Missouri jury has reached a defense verdict in favor of Johnson & Johnson at the conclusion of a talcum powder ovarian cancer case, HarrisMartin Publishing is reporting.
The Mississippi Supreme Court has granted a motion by several Valeant companies to dismiss an appeal pending in a talcum powder action brought by the state’s Mississippi Attorney General, according to documents filed recently.
Calif. Court Weighs in on J&J Demurrers to Talc Complaints, Finds Fault with Negligence Per Se, Aiding and Abetting Claims
The California court overseeing the state’s coordinated talcum powder personal injury docket has issued a tentative ruling weighing in on demurrers filed by J&J against the plaintiffs’ claims, concluding in part that the plaintiffs’ Second Amended Complaint is “sufficiently clear to apprise each J&J entity of the conduct at issue in this lawsuit.”
Jurors set to weigh in on talcum powder ovarian cancer claims in Missouri are expected to hear closing arguments on Friday, Dec. 20, sources confirmed to HarrisMartin.
Jurors in California have reached a defense verdict for Johnson & Johnson at the conclusion of an asbestos cosmetic talcum powder trial, rejecting claims that the plaintiff’s mesothelioma was caused by exposure to asbestos in the products.
Imerys Talc America has filed for an extension of time in which to file its Chapter 11 bankruptcy reorganization plan, the third time it has requested more time in which to file extend the exclusive periods.
A defendant named in a number of ovarian cancer talcum powder cases pending in Florida state court has opposed recent efforts by plaintiffs to consolidate cases pending in the county, maintaining that “consolidation will not conserve the resources of the Court or the parties.”